Members of the phylum Microspora are all obligate intracellular parasites. Little is known concerning metabolic pathways in these parasites, some of which pose serious problems in immunocompromised patients. We investigated polyamine metabolism in the systemic pathogen Enterocytozoon cuniculi using intact pre-emergent spores, and cell-free preparations. We found both polyamine synthetic and interconversion pathways to be operative, as evidenced by conversion of ornithine into polyamines, and production of spermidine from spermine by pre-emergent spores. Recent developments in the antitumour field have highlighted the ability of bis-ethylated polyamine analogues to reduce polyamine levels and block growth of tumour cells. In light of enhanced polyamine uptake in Enc. cuniculi, we have begun to study bis-aryl 3-7-3 and bis-ethyl oligoamine analogues as leads for chemotherapy of microsporidia.
The group of organisms known as the Microsporidia comprises the phylum Microspora with over 1200 organisms, all of which are obligate intracellular parasites in invertebrate or vertebrate hosts. Although the first human case of microsporidiosis was only reported in 1959, the advent of a large number of immunocompromised individuals with AIDS has resulted in an increase in the number of human cases of microsporidiosis [1, 2] . Of the human pathogens, the genera Enterocytozoon and Encephalitozoon have several prominent human pathogens (Enc. hellum, Enc. cuniculi, Enc. intestinalis and Ent. bienusi [1] ). The mainstays of chemotherapy for microsporidian infections are fumigillin and benzimidazoles; however, since these agents may fail to cure, and often result in relapses when treatment is withdrawn [3] [4] [5] , other more effective agents are needed. We are investigating the metabolism of polyamines in Enc. cuniculi, including polyamine synthesis and interconversion in intact pre-emergent spores and the activities of enzymes of polyamine synthesis interconversion in mature spores in an effort to uncover potential drug targets. In these studies bis-aryl-substituted 3-7-3 and oligoamine analogues have emerged as lead compounds for chemotherapy.
Enc. cuniculi, a systemic parasite of humans [1] , can be maintained using a rabbit kidney cell line (RK-13), as well as in HEK cells ( [6] and C.J. Bacchi and D. Rattendi, unpublished work). Homogenates of infected cells are prefiltered and pre-emergent spores with significant metabolic activity are then harvested employing a Percoll gradient procedure [7] . Using these techniques one can separate light (1.018-1.035 g/ml) and heavy (1.102-1.119 g/ml) fractions which are metabolically active. Electron microscopy of these fractions indicated the heavy fraction was homogeneous for pre-emergent spores [8] . These intact pre-emergent spores were used in metabolic studies. Mature spores for metabolic studies were obtained from culture supernatants, washed in buffer with 1% SDS and disrupted with glass beads [9] .
Polyamines (putrescine, spermidine, spermine) are aminecontaining catonic, low-molecular-mass compounds found to be ubiquitous in eukaryotes and prokaryotes. They function in cell proliferation and are essential for cell division and a range of metabolic functions including synthesis of macromolecules and structural integrity of nucleic acids [10] . Their intracellular concentrations are carefully controlled through synthesis, uptake, interconversion and degradation [10] . Synthesis of polyamines in most cells is initiated by conversion of ornithine to putrescine via ornithine decarboxylase (ODC; Figure 1 ). One or two aminopropyl groups are added to the N-terminal groups of putrescine to form spermidine and spermine respectively, via the appropriate synthases. S-Adenosylmethionine (AdoMet) is decarboxylated by (putrescine-or Mg 2+ -activated) AdoMet decarboxylase (AdoMetDC). Control over the synthetic pathway is exerted by the short half-lives and rapid turnover of ODC and AdoMetDC, and by synthesis of an ODC-specific protein, antizyme, which binds to the N-terminus and inhibits ODC activity [11] . Most cells can take up polyamines which can then be back-converted to spermidine and putrescine by a spermidine/spermine-N 1 -acetyltransferase (SSAT) and polyamine oxidase (PAO [11] ). Regulation of polyamine interconversion in most mammalian cells is controlled by SSAT, which is inducible to 1000-2000-fold over controls in the presence of extracellular polyamines [12] . In addition, acetylated polyamines, as opposed to unaltered free amines, can be excreted from the cell. Recently spermine oxidase has been isolated from tumour cells, which converts spermine directly into spermidine and 3-aminopropanol, and does not use acetylated polyamines as substrates. It is postulated that this enzyme is used to directly convert spermine into spermidine whereas SSAT/PAO would be used for elimination of excess polyamines [13] . Thus through the regulatory action of ODC, AdoMetDC and SSAT, as well as polyamine uptake and excretion of acetylated derivatives, intracellular polyamine levels are maintained at constant levels. Relatively little is known concerning metabolism in the Microsporidia, save for a study of glycolytic enzymes [14] . The Microsporidia are eukaryotes containing a nucleus with a nuclear membrane, chromosomes separable by mitotic spindles and an intracellular membrane system [1] ; however, members of this phylum have no centrioles or standard mitochondria.
Studies on polyamine metabolism were initiated by determining concentrations of polyamines in pre-emergent spores. Pre-emergent spores in the heavy fraction contained about 1.6 times as much spermine (38.15 ± 27.8 nmol/mg of protein) as spermidine (23 ± 15.8 nmol/mg of protein). Cadaverine (1,5-diaminopentane) and putrescine were not detected using sensitive reversed-phase HPLC methodology and fluorescence detection (limit, 50 pmol/mg of protein [15] ).
ODC, AdoMetDC, SSAT and PAO activities were detectable in mature spores, with activities of 25, 123, 10.2 and 1913 nmol/mg of protein per 2 h, respectively. ODC activity was inhibited by D,L-α-difluoromethylornithine (DFMO), but not by difluoromethylarginine. Arginine decarboxylase ('ADC') activity (plant pathway) was not detected at either pH 6.5 or 7.5. The ratios of activities of PAO/ODC and PAO/AdoMetDC were 76 and 15.5 respectively.
Pre-emergent spores (heavy gradient fractions) obtained from a Percoll gradient were incubated in a physiological buffer used to induce excystation of Nosema sp. spores, containing NAD + , ATP, glucose, sodium pyruvate, acetylCoA and other nutrients useful for intracellular parasites [15] . Polyamine synthesis from [ 3 H]ornithine was found in these spores to have about an 8-fold lower activity than uptake of [ 14 C]spermine and conversion into spermidine over a 2 h period. Thus from the SSAT/PAO data and the spermine versus ornithine uptake it appears that Enc. cuniculi relies heavily on uptake and interconversion of polyamines, rather than synthesis, for maintaining polyamine levels. This profile of polyamine metabolism, low synthetic activity versus elevated uptake and interconversion, argues against the utility of classic inhibitors of polyamine synthesis such as the ODC inhibitor, DFMO, and the AdoMet analogue 5 -{[(Z)-4-amino-2-butenyl]methylamino}-5 -deoxyadenosine (AbeAdo, or MDL 73811), since uptake of polyamines replaces those lost through inhibition of synthesis.
Studies on polyamines as drug targets for the therapy of cancer and other diseases initially focused on the inhibition Figure 2 Structures of some polyamine analogues Tetra-amines, penta-amines and oligoamines were synthesized as described previously [17] . Compound no. 24 was synthesized as described in [21] . BENSpm is bisethyl norspermine or BE 3-3-3; MDL 27695 is bis-benzyl 3-7-3; SL11061 is BE-4-4-4-4.
Table 1 Polyamine analogues as inhibitors of Enc. cuniculi growth in vitro and in vivo
IC 50 values were determined using 24-well plates with confluent RK-13 monolayers infected with 10 6 spores. After a 50-80% infection rate, compounds were added to duplicate wells and the medium was changed at 3 and 6 days. On day 8, cells were fixed overnight, stained with Giemsa and 5 confluent fields (240 cells/field) were counted using an inverted phase microscope (400×). The percentage of infected cells in untreated controls was compared with cells in the presence of the compound, and the results expressed as 50% inhibitory concentration (IC 50 s; [22] ). To calculate the lowest dose for >90% cures two animal models were used : C57/B16 CD8 and BALB/c/nunu. Animals were infected with 10 6 -10 7 spores and single daily intraperitoneal injections were given starting 24 h post-infection. Untreated controls died 20-27 days post-infection. Cured mice were observed >20 days beyond control deaths, and had no evidence of parasites by PCR and standard histological analysis [21] [22] [23] [24] . of synthetic enzymes, ODC and AdoMetDC. However, it became apparent that most cancer cells could transport and interconvert polyamines, negating effects of inhibitors such as DFMO. Emphasis then switched to polyamine analogues which are transported into cells, up-regulating SSAT, while down-regulating polyamine synthesis. The net effect of these compounds is depletion of polyamines, due to excessive acetylation and excretion of intracellular amines, and is followed by cytostasis, apoptosis and cell death. The initial polyamine analogs evaluated were bis-ethylated 3-3-3 (bis-ethylnorspermine) or 3-4-3 (bis-ethylhomospermine) derivatives (Figure 2 ). These were effective inhibitors of cell growth but were variably toxic, and had short half-lives in plasma [16] . Another class of analogues evaluated was the series of bis-benzylated 3-7-3 derivatives synthesized by Marion Merrell-Dow in the late 1980s and which served as substrates for mammalian polyamine oxidase [17] . Recent developments in the cancer chemotherapy field have sought to improve on existing polyamine analogues as potential antitumour agents [16, 18] . [16] . Based on the ability of Enc. cuniculi to assimilate and interconvert exogenous spermine, the effect of polyamine analogues on the growth of Enc. cuniculi in an in vitro screen using RK-13 cells as the host monolayer was examined [19] . Over 50 tetra-, penta-and oligoamines ( Figure 2 ) as well as bis-benzyl-substituted 3-7-3 analogues were evaluated and the IC 50 values determined for each compound [20, 21] . Of nearly 50 compounds tested, five were found to have activity warranting in vivo testing in mouse model infections ( Table 1 ). The effective agents represented the major classes of analogues, and all were effective in curing well-validated mouse models in which animals were dosed, once daily for 10 days, given as a 5 day-dosing/2 days off/5 day-dosing regimen ( Table 1 ). All the agents used were well tolerated at the effective dosages. Most agents were active at 1 or 1.25 mg/kg, yielding 100% cure rates, based on histological examination and PCR analysis [22, 23] .
In vivo
Since similar analogues have been found to serve as substrates for mammalian PAO [e.g. the bis(3-phenyl benzyl) 3-7-3 polyamine analogue BW-1] or to super-induce SSAT [17, 18] , an important future direction will be to determine whether these mechanisms of activity are operable in the Microsporidia or other parasites.
